ABBOTT HEALTHCARE PRODUCTS LTD
Get an alert when ABBOTT HEALTHCARE PRODUCTS LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£94m
+21.4% highest in 3 filed years
Employees
1
-50% lowest in 3 filed years
Profit before tax
£19m
+7.3% highest in 3 filed years
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £2,291,000 | £1,221,000 | £661,000 | -45.9% | |
| Operating profit | £50,000 | -£139,000 | £27,000 | +119.4% | |
| Profit before tax | £13,794,000 | £17,567,000 | £18,851,000 | +7.3% | |
| Net profit | £11,969,000 | £15,345,000 | £16,557,000 | +7.9% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | £62,062,000 | £77,407,000 | £93,964,000 | +21.4% | |
| Net assets | £62,062,000 | £77,407,000 | £93,964,000 | +21.4% | |
| Equity | £62,062,000 | £77,407,000 | £93,964,000 | +21.4% | |
| Average employees | 7 | 2 | 1 | -50% | |
| Wages | £1,476,000 | £979,000 | £290,000 | -70.4% | |
| Directors' remuneration | — | £0 | £0 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 2.2% | -11.4% | 4.1% | |
| Return on capital employed | 0.1% | -0.2% | 0.0% | |
| Gearing (liabilities / total assets) | 14.0% | 16.9% | 18.5% | |
| Current ratio | 5.85x | 5.08x | 4.79x | |
| Interest cover | 1.72x | — | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- ABBOTT HEALTHCARE PRODUCTS LTD 2010-02-17 → present
- SOLVAY HEALTHCARE LIMITED 1995-06-12 → 2010-02-17
- DUPHAR LABORATORIES LIMITED 1969-03-05 → 1995-06-12
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young, Chartered Accountants
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company generated a net profit of £16,557,000 (2024: net profit £15,345,000), has net assets of £93,964,000 (2024: net assets of £77,407,000) and current assets of the Company exceeded its current liabilities by £80,910,000 (2024: £64,353,000). Trading profits are expected to continue in the foreseeable future.”
Group structure
- ABBOTT HEALTHCARE PRODUCTS LTD · parent
- British Colloids Limited 100%
Significant events
- “A number of Abbott group companies in the UK, including the Company, are participants in an HMRC profit division compliance facility (PDCF) process including a subsequent tax enquiry process. Included within the Corporation tax liability is a provision of £200,000 (2024: £200,000).”
- “It is possible that an additional liability might arise from HMRC enquiries, it is not possible in the view of the Directors to estimate that additional liability.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 33 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GOGAY, Kevan | Secretary | 2015-02-13 | — | — |
| CAMPBELL, Ross Iain | Director | 2025-04-25 | Apr 1976 | British |
| CLAYTON, Michael Robert Kendall | Director | 2020-03-23 | Apr 1974 | British |
| WENNER, James Russell | Director | 2025-12-10 | Sep 1967 | American |
Show 33 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOOTE, Michael George Ernest | Secretary | — | 1996-09-30 |
| CHAPMAN, Michael James | Secretary | 1996-10-01 | 1998-12-31 |
| DAWES, Melvin John | Secretary | 1999-01-01 | 2001-02-23 |
| ABOGADO NOMINEES LIMITED | Corporate Secretary | 2010-02-15 | 2015-02-13 |
| SOLVAY UK HOLDING COMPANY LIMITED | Corporate Secretary | 2001-02-23 | 2010-02-15 |
| BARRACLOUGH, Richard Alan | Director | 1996-09-03 | 1999-09-30 |
| BOOTE, Michael George Ernest | Director | — | 1996-09-03 |
| BROECKS, Bert Christian | Director | 2003-06-16 | 2006-12-12 |
| BROENS, Daniel | Director | 2001-03-05 | 2006-12-12 |
| DAVIES, Alison Elizabeth | Director | 2023-10-15 | 2025-12-10 |
| DE LAVENNE DE LA MONTOISE, Bertrand | Director | 2013-07-01 | 2014-12-12 |
| DE SLOOVER, Christian, Dr | Director | 1997-10-01 | 1999-06-30 |
| DEE, Thomas Joseph | Director | 2010-02-15 | 2013-09-30 |
| DUQUENNE, Thierry Amaury Adrien Marie | Director | 2006-12-12 | 2008-01-01 |
| ERNST, Jurgen | Director | 1997-10-01 | 2005-01-01 |
| FREYMAN, Thomas Craig | Director | 2010-02-15 | 2015-12-15 |
| HALL, Gary James | Director | 2015-10-02 | 2018-09-27 |
| HARRIS, Neil | Director | 2018-08-31 | 2025-04-25 |
| HUDSON, Susan Michelle | Director | 2016-11-28 | 2018-08-31 |
| KOZMINA, Natalia Sergeyevna | Director | 2011-07-20 | 2013-05-31 |
| KRAMMER, Karen Ann | Director | 2020-03-01 | 2022-09-19 |
| MCCOY JR, John Arthur | Director | 2022-09-19 | 2023-10-15 |
| MOUNTRICHAS, Georgios | Director | 2018-09-27 | 2020-03-23 |
| PETER, John Beverly, Dr | Director | — | 2008-01-01 |
| SAKSIDA, Kristian Thomas Dominic | Director | 1999-09-30 | 2003-06-30 |
| SMITH, Michael James | Director | 2015-02-13 | 2015-10-02 |
| TRAVERSE, Bertrand | Director | 2007-04-20 | 2010-02-15 |
| VAN ROYE, Gerard Jean Marie | Director | 2008-01-01 | 2010-02-15 |
| WEIDAUER, Thomas Jurgen, Dr | Director | 2008-01-01 | 2011-03-15 |
| WEITEKAMPER, Frank | Director | 2010-02-15 | 2017-01-05 |
| WESSOLOWSKI, Jurgen | Director | 1999-07-19 | 2012-10-30 |
| WITTELAAR, Joseph | Director | — | 1999-04-16 |
| YOOR, Brian | Director | 2015-12-15 | 2020-02-29 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Abbott Laboratories | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
| Abbott Laboratories Inc. | Corporate entity | Shares 75–100%, Voting 75–100% (as trust) | 2016-04-06 | Active |
Filing timeline
Last 20 of 190 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-04 | AA | accounts | Accounts with accounts type full | |
| 2025-12-15 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-15 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-08 | AA | accounts | Accounts with accounts type full | |
| 2025-05-01 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-30 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-22 | AA | accounts | Accounts with accounts type full | |
| 2024-04-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-25 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-25 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-24 | AA | accounts | Accounts with accounts type full | |
| 2023-03-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-27 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-27 | TM01 | officers | Termination director company with name termination date | |
| 2022-08-09 | AA | accounts | Accounts with accounts type full | |
| 2022-03-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-10-07 | AA | accounts | Accounts with accounts type full | |
| 2021-03-24 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.